Home
/
Merck & Co., Inc.
/
Financials
/
Quarterly
Merck & Co., Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Merck & Co., Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$17.28B
Nov 5, 2025
Q2
2025
Jun 30, 2025
$15.81B
Aug 5, 2025
Q1
2025
Mar 31, 2025
$15.53B
May 2, 2025
Q3
2025
Sep 30, 2024
$16.66B
Nov 5, 2025
Q2
2025
Jun 30, 2024
$16.11B
Aug 5, 2025
Q1
2025
Mar 31, 2024
$15.78B
May 2, 2025
Q3
2024
Sep 30, 2023
$15.96B
Nov 6, 2024
Q2
2024
Jun 30, 2023
$15.04B
Aug 5, 2024
Q1
2024
Mar 31, 2023
$14.49B
May 3, 2024
Q3
2023
Sep 30, 2022
$14.96B
Nov 3, 2023
Q2
2023
Jun 30, 2022
$14.59B
Aug 7, 2023
Q1
2023
Mar 31, 2022
$15.90B
May 5, 2023
Q3
2022
Sep 30, 2021
$13.15B
Nov 3, 2022
Q2
2022
Jun 30, 2021
$11.40B
Aug 5, 2022
Q1
2022
Mar 31, 2021
$10.63B
May 5, 2022
Q3
2021
Sep 30, 2020
$10.93B
Nov 5, 2021
Q2
2021
Jun 30, 2020
$9.35B
Aug 9, 2021
Q1
2021
Mar 31, 2020
$12.06B
May 5, 2021
Q3
2020
Sep 30, 2019
$12.40B
Nov 5, 2020
Q2
2020
Jun 30, 2019
$11.76B
Aug 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2011
Mar 31, 2011
$11.58B
May 9, 2011
Q1
2011
Mar 31, 2010
$11.42B
May 9, 2011
Q3
2009
Sep 30, 2009
$4.50B
Oct 29, 2009
Q2
2009
Jun 30, 2009
$4.65B
Jul 24, 2009
Q3
2009
Sep 30, 2008
$4.58B
Oct 29, 2009
Q2
2009
Jun 30, 2008
$4.92B
Jul 24, 2009
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.79B
Nov 5, 2025
Q2
2025
Jun 30, 2025
$4.43B
Aug 5, 2025
Q1
2025
Mar 31, 2025
$5.08B
May 2, 2025
Q3
2025
Sep 30, 2024
$3.16B
Nov 5, 2025
Q2
2025
Jun 30, 2024
$5.46B
Aug 5, 2025
Q1
2025
Mar 31, 2024
$4.76B
May 2, 2025
Q3
2024
Sep 30, 2023
$4.75B
Nov 6, 2024
Q2
2024
Jun 30, 2023
($5.98B)
Aug 5, 2024
Q1
2024
Mar 31, 2023
$2.82B
May 3, 2024
Q3
2023
Sep 30, 2022
$3.25B
Nov 3, 2023
Q2
2023
Jun 30, 2022
$3.94B
Aug 7, 2023
Q1
2023
Mar 31, 2022
$4.31B
May 5, 2023
Q3
2022
Sep 30, 2021
$4.57B
Nov 3, 2022
Q2
2022
Jun 30, 2021
$1.55B
Aug 5, 2022
Q1
2022
Mar 31, 2021
$3.18B
May 5, 2022
Q3
2021
Sep 30, 2020
$2.94B
Nov 5, 2021
Q2
2021
Jun 30, 2020
$3.00B
Aug 9, 2021
Q1
2021
Mar 31, 2020
$3.22B
May 5, 2021
Q3
2020
Sep 30, 2019
$1.90B
Nov 5, 2020
Q2
2020
Jun 30, 2019
$2.67B
Aug 5, 2020